Washington, DC 20006-5349
HELPLINE
CAR-T (Chimeric antigen receptor) cell therapy is a type of immunotherapy that uses a patient’s T cells to attack cancer cells. T cells are white blood cells that fight infection and illness, but cancer cells can sometimes trick the immune system. CAR T-cell therapy helps the body’s immune system see…
In this episode of MesoTV, three patients, two with peritoneal mesothelioma and one with pleural mesothelioma, tell their stories of diagnosis, treatment, subsequent recurrence, and…
The field of integrative medicine combines conventional therapies with complementary ones in a thoughtful way to optimize outcomes and/or quality of life. Services provided under…
This episode of MesoTV features Jacob Strand, MD in an interview with Mesothelioma Applied Research Foundation’s nurse, Julie White, RN, BSN, OCN. The topic of…
Melina Marmarelis, MD, Thoracic Medical Oncologist, UPenn joins us for an interview about precision medicine for mesothelioma. She discusses biomarker information, such as histology (currently…
Due to recent advances in cancer treatment, especially in the field of immunotherapy, chemotherapy treatment options for mesothelioma have taken a back seat. However, this…
In this episode, we interview Cristobal. After some concerning abdominal pain brought him to his doctor and started a chain reaction of tests, Cristobal’s diagnosis…
Watch the video of Dr. Pingpank as he discusses mesothelioma surgery and treatment at UMPC. We meet today with Dr. James Pingpank of the Hillman…
Andreas Rimner, MD, Memorial Sloan Kettering Cancer Center, joins us for a conversation about radiation oncology and currently available clinical trials. He discussed various ways…
In this episode of MesoTV, we are joined by Dr. Ibiayi Dagogo-Jack a thoracic oncologist at the Massachusetts General Hospital and assistant professor of medicine…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
